Menu

History

We were formed in 2017 to accelerate access to healthcare by tackling market inefficiencies.

By the end of 2022, our agreements had helped more than 530 million people in over 95 countries access medical innovations.

A new way to tackle access challenges

MedAccess was born out of the recognition by global health partners including the Clinton Health Access Initiative (CHAI), the Bill & Melinda Gates Foundation and the former UK Department for International Development (DFID) that unpredictable healthcare markets are a major barrier to access in many countries.

DFID commissioned CDC Group, now British International Investment (BII), to develop an idea for an organisation focused on shaping healthcare markets in low- and middle-income countries. CDC’s investment experts developed the Credit Facility for Access to Medicine – later renamed MedAccess.

The company was established in November 2017 with the clear aim to blend private sector knowhow with public health expertise, using $200 million paid-in capital to negotiate agreements that reduced the price and increased availability of medical innovations.

We are independent and not for profit, with any operating surplus is invested into developing new agreements to speed up access to healthcare.

From first steps to growing impact

We announced our first agreement, with Hologic, in July 2018.

Since then, we have provided eight further guarantees to increase access to medical innovations that tackle HIV, malaria, tuberculosis, COVID-19 and syphilis.

To date, our guarantees have helped accelerate access to health products for more than 375 million people in over 90 countries.

BII remains MedAccess’ sole shareholder.

See our agreements

MedAccess timeline

Expand all

2022

Health care workers are vaccinated against COVID-19, Sudan

June

Launch of procurement guarantee with the Open Society Foundations to help meet country demand for COVID-19 vaccines via COVAX’s cost-sharing mechanism.

The Wondfo HIV self-test

July

Launch of volume guarantee to catalyse access to Wondfo’s HIV self-test, in partnership with CHAI.

A doctor using the G6PD testing device

September

Launch of volume guarantee to catalyse access to SD Biosensor’s G6PD testing devices and strips, in partnership with PATH.

Helen Rees

October

Professor Helen Rees OBE appointed Board Chair.

2021

UNICEF supports the Government of Niger, IOM, and partners to deliver aid to migrants in the midst COVID-19

March

UNICEF procurement guarantee for essential COVID-19 and non-COVID-19 products extended by one year.

Patient volunteer Andrew Gwesele at Highfields Polyclinic, Highfields Township, Harare, Zimbabwe. shares his experience taking 3HP

July

Launch of volume guarantee to catalyse access to Macleods’ 3HP latent tuberculosis treatment, in partnership with CHAI and Unitaid.

Mothers line-up and wait for their children to receive the malaria vaccine, Mkaka Primary School Outreach, Malawi

August

Launch of innovative financing agreement with Gavi and GSK to support continued production of RTS,S malaria vaccine antigen ahead of key policy and funding decisions. MedAccess comes off risk in December when positive policy and funding decisions are announced.

The dual test for HIV and syphilis requires a single finger-prick blood sample and gives results in 20 minutes

November

Launch of volume guarantee to catalyse access to SD Biosensor’s HIV and syphilis dual test, in partnership with CHAI.

2020

Health professionals line up to administer Angola's first COVID-19 vaccines on behalf of the COVAX facility

July

Launch of procurement guarantee for UNICEF to accelerate procurement of essential COVID-19 and non-COVID-19 supplies.

2019

Infants, children under five and pregnant women are the most vulnerable groups to malaria

October

Launch of volume guarantee for BASF’s Interceptor® G2 mosquito nets announced at Global Fund replenishment event, in partnership with the Bill & Melinda Gates Foundation.

A graph

November

BII pays in further $100 million capital, taking MedAccess’ capitalisation to $200 million.

2018

Nigel Keen

January

Nigel Keen appointed Board Chair. First $100 million of paid-in capital issued by BII.

The Panther viral load testing machine

July

Launch of volume guarantee for Hologic’s Panther® viral load testing platform announced at AIDS 2018 conference, in partnership with the Clinton Health Access Initiative (CHAI).

2017

An image of money and graphs

September

$200m capital authorised by British International Investment (BII) in preparation for MedAccess’ incorporation.

Michael Anderson

November

MedAccess formally incorporated. Michael Anderson begins work as CEO.

Close
Close